Drug interactions for the following drug(s)
Applies to: Acyclovir 50 MG Buccal Tablet <> mycophenolate mofetil 500 MG Oral Tablet
Acyclovir may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: Alendronic acid 70 MG Oral Tablet <> mycophenolate mofetil 500 MG Oral Tablet
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Mycophenolate mofetil.
Applies to: Prograf 1 MG Oral Capsule <> Alendronic acid 70 MG Oral Tablet
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tacrolimus is combined with Alendronic acid.
Applies to: Acyclovir 400 MG Oral Tablet <> Prograf 1 MG Oral Capsule
Tacrolimus may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Applies to: Acyclovir 50 MG Buccal Tablet <> Alendronic acid 70 MG Oral Tablet
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Acyclovir is combined with Alendronic acid.
Applies to: Prograf 1 MG Oral Capsule <> mycophenolate mofetil 500 MG Oral Tablet
Tacrolimus may increase the immunosuppressive activities of Mycophenolate mofetil.
Applies to: Acyclovir 50 MG Buccal Tablet <> Prograf 1 MG Oral Capsule
Tacrolimus may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Alendronic acid 70 MG Oral Tablet
The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Mycophenolate mofetil.
Applies to: Acyclovir 400 MG Oral Tablet <> Alendronic acid 70 MG Oral Tablet
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Acyclovir is combined with Alendronic acid.
Applies to: Alendronic acid 70 MG Oral Tablet <> Prograf 1 MG Oral Capsule
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tacrolimus is combined with Alendronic acid.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Prograf 1 MG Oral Capsule
Tacrolimus may increase the immunosuppressive activities of Mycophenolate mofetil.
Applies to: Acyclovir 400 MG Oral Tablet <> mycophenolate mofetil 500 MG Oral Tablet
Acyclovir may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Acyclovir 50 MG Buccal Tablet <> mycophenolate mofetil 500 MG Oral Tablet
Drug1 (rxcui = 1423662, name = acyclovir 50 MG Buccal Tablet, tty = SCD). Drug2 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to acyclovir, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Acyclovir and Mycophenolate mofetil.
Applies to: Alendronic acid 70 MG Oral Tablet <> mycophenolate mofetil 500 MG Oral Tablet
Drug1 (rxcui = 904431, name = alendronic acid 70 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to alendronate, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Alendronic acid and Mycophenolate mofetil.
Applies to: Prograf 1 MG Oral Capsule <> Alendronic acid 70 MG Oral Tablet
Drug1 (rxcui = 108513, name = tacrolimus 1 MG Oral Capsule [Prograf], tty = SBD). Drug2 (rxcui = 904431, name = alendronic acid 70 MG Oral Tablet, tty = SCD). Drug1 is resolved to tacrolimus, Drug2 is resolved to alendronate and interaction asserted in DrugBank between Tacrolimus and Alendronic acid. Drug1 is resolved to tacrolimus, Drug2 is resolved to alendronic acid and interaction asserted in DrugBank between Tacrolimus and Alendronic acid. Drug1 is resolved to anhydrous tacrolimus, Drug2 is resolved to alendronic acid and interaction asserted in DrugBank between Tacrolimus and Alendronic acid.
Applies to: Acyclovir 400 MG Oral Tablet <> Prograf 1 MG Oral Capsule
Drug1 (rxcui = 197311, name = acyclovir 400 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 108513, name = tacrolimus 1 MG Oral Capsule [Prograf], tty = SBD). Drug1 is resolved to acyclovir, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Acyclovir and Tacrolimus. Drug1 is resolved to acyclovir, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Acyclovir and Tacrolimus.
Applies to: Acyclovir 50 MG Buccal Tablet <> Alendronic acid 70 MG Oral Tablet
Drug1 (rxcui = 1423662, name = acyclovir 50 MG Buccal Tablet, tty = SCD). Drug2 (rxcui = 904431, name = alendronic acid 70 MG Oral Tablet, tty = SCD). Drug1 is resolved to acyclovir, Drug2 is resolved to alendronic acid and interaction asserted in DrugBank between Acyclovir and Alendronic acid. Drug1 is resolved to acyclovir, Drug2 is resolved to alendronate and interaction asserted in DrugBank between Acyclovir and Alendronic acid.
Applies to: Prograf 1 MG Oral Capsule <> mycophenolate mofetil 500 MG Oral Tablet
Drug1 (rxcui = 108513, name = tacrolimus 1 MG Oral Capsule [Prograf], tty = SBD). Drug2 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to tacrolimus, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Tacrolimus and Mycophenolate mofetil.
Applies to: Acyclovir 50 MG Buccal Tablet <> Prograf 1 MG Oral Capsule
Drug1 (rxcui = 1423662, name = acyclovir 50 MG Buccal Tablet, tty = SCD). Drug2 (rxcui = 108513, name = tacrolimus 1 MG Oral Capsule [Prograf], tty = SBD). Drug1 is resolved to acyclovir, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Acyclovir and Tacrolimus. Drug1 is resolved to acyclovir, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Acyclovir and Tacrolimus.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Alendronic acid 70 MG Oral Tablet
Drug1 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 904431, name = alendronic acid 70 MG Oral Tablet, tty = SCD). Drug1 is resolved to mycophenolate mofetil, Drug2 is resolved to alendronic acid and interaction asserted in DrugBank between Mycophenolate mofetil and Alendronic acid.
Applies to: Acyclovir 400 MG Oral Tablet <> Alendronic acid 70 MG Oral Tablet
Drug1 (rxcui = 197311, name = acyclovir 400 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 904431, name = alendronic acid 70 MG Oral Tablet, tty = SCD). Drug1 is resolved to acyclovir, Drug2 is resolved to alendronic acid and interaction asserted in DrugBank between Acyclovir and Alendronic acid. Drug1 is resolved to acyclovir, Drug2 is resolved to alendronate and interaction asserted in DrugBank between Acyclovir and Alendronic acid.
Applies to: Alendronic acid 70 MG Oral Tablet <> Prograf 1 MG Oral Capsule
Drug1 (rxcui = 904431, name = alendronic acid 70 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 108513, name = tacrolimus 1 MG Oral Capsule [Prograf], tty = SBD). Drug1 is resolved to alendronate, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Alendronic acid and Tacrolimus.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Prograf 1 MG Oral Capsule
Drug1 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 108513, name = tacrolimus 1 MG Oral Capsule [Prograf], tty = SBD). Drug1 is resolved to mycophenolate mofetil, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Mycophenolate mofetil and Tacrolimus.
Applies to: Acyclovir 400 MG Oral Tablet <> mycophenolate mofetil 500 MG Oral Tablet
Drug1 (rxcui = 197311, name = acyclovir 400 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to acyclovir, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Acyclovir and Mycophenolate mofetil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.